Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids

Last updated: January 10, 2020
Sponsor: Kasr El Aini Hospital
Overall Status: Active - Not Recruiting

Phase

4

Condition

Hair Loss

Alopecia

Treatment

N/A

Clinical Study ID

NCT04228029
KasrEliniH
  • Ages 18-50
  • All Genders

Study Summary

Patients with three lesions of alopecia areata are randomly recruited in this study. Each lesion is randomized in to receiving either carboxytherapy in one lesion, intralesional steroids in another lesion and combination of both in the third lesion.

Treatment period is 3 months followed by a follow-up period of 2 months.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • early localized scalp alopecia areata

  • patients who did not receive any medication for at least 2 months before starting thestudy Patients who agreed to join the study and signed written consent.

Exclusion

Exclusion Criteria:

  • pregnant, and lactating females and those with unrealistic expectation.

  • Alopecia totalis or universalis or ophiasis or cicatrising alopecia

  • Usage of systemic treatment of alopecia areata 2 months prior to the study.

  • Any scalp lesion within the treated area

  • Bleeding diathesis, severe anemia or platelet disorders

  • Medical conditions such as autoimmune diseases.

Study Design

Total Participants: 30
Study Start date:
August 20, 2019
Estimated Completion Date:
April 20, 2020

Connect with a study center

  • Kasr ElAiny Hospital, Cairo university

    Cairo, El Manial 11956
    Egypt

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.